InvestorPlace - Stock Market News, Stock Advice & Trading Tips
As AMRN stock's future will likely depend on how strong sales of Vascepa will be, investors may want to wait for the upcoming Q4 numbers before investing in Amarin shares.
The post Positive Catalysts Make Amarin Stock a Buy on Current Weakness appeared first on InvestorPlace.
More From InvestorPlace